The global nasal drug delivery systems marketsize is expected to reach $67.99 billion by 2025, expanding at a compound annual growth rate (CAGR) of 6,5%, according to a new report by Grand View Research.
Rising awareness about nasal products is one of the major factors driving the market.
Growing geriatric population is also expected to have positive impact on the market.
According to the United Nations Department of Economic and Social Affairs, the global geriatric population (60 years and above), was around 962 million in 2017.
The number is expected to grow, particularly in Latin America with 71% rise in population aged 60 and over, followed by Asia (66%), Africa (64%), North America (41%), and Europe (23%).
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze